{"id":342593,"date":"2025-08-20T18:36:33","date_gmt":"2025-08-20T18:36:33","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-biontech-se\/"},"modified":"2025-08-20T18:36:33","modified_gmt":"2025-08-20T18:36:33","slug":"how-to-buy-biontech-se","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/","title":{"rendered":"How to buy BioNTech SE (BNTX) shares &#8211; Investment in BioNTech SE (BNTX) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334027,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-342593","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy BioNTech SE (BNTX) Shares - Investment in BioNTech SE (BNTX) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy BioNTech SE (BNTX) Shares - Investment in BioNTech SE (BNTX) Stock"},"description":"Learn how to buy BioNTech SE (BNTX) shares and invest in this innovative mRNA technology leader. Discover current price, risks, and growth potential for 2025-2030.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy BioNTech SE (BNTX) shares and invest in this innovative mRNA technology leader. Discover current price, risks, and growth potential for 2025-2030."},"intro":"Thinking about investing in the company that revolutionized vaccine technology? BioNTech SE (BNTX) represents more than just COVID-19 success - it's a pioneering force in mRNA medicine with ambitious cancer treatment goals. This German biotech giant is transforming from pandemic hero to oncology innovator, offering investors exposure to cutting-edge medical technology. Let's explore why BioNTech deserves your attention and how to strategically approach this investment opportunity.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in the company that revolutionized vaccine technology? BioNTech SE (BNTX) represents more than just COVID-19 success - it's a pioneering force in mRNA medicine with ambitious cancer treatment goals. This German biotech giant is transforming from pandemic hero to oncology innovator, offering investors exposure to cutting-edge medical technology. Let's explore why BioNTech deserves your attention and how to strategically approach this investment opportunity."},"body_html":"<h2>\ud83d\udcc8 BioNTech Stock: Current Price and Critical Dates<\/h2> <p>As of August 20, 2025, BioNTech SE (BNTX) trades at <strong>$111.40<\/strong> on the NASDAQ exchange. Mark your calendar: <strong>November 3, 2025<\/strong> is your next major opportunity. That's when BioNTech releases its Q3 earnings, and historically, these reports create significant price movements.<\/p> <p><strong>Recent Earnings Impact Analysis:<\/strong><br\/> The August 4, 2025 Q2 earnings showed a fascinating pattern - despite missing EPS estimates (-$1.60 vs. -$1.41 expected), the stock actually gained 0.9% to $111.05 the next day (<a href=\"https:\/\/www.benzinga.com\/analyst-stock-ratings\/price-target\/25\/08\/46866575\/these-analysts-revise-their-forecasts-on-biontech-after-q2-results\">Benzinga Analysis<\/a>). Why? Because revenue smashed expectations at $306.46 million versus $161.26 million forecasted, proving that investors value growth potential over short-term losses in biotech.<\/p> <p>This pattern isn't new. Over the past six earnings cycles, BioNTech has shown:<\/p> <ul> <li><strong>50% positive reactions<\/strong> in the first 3 days post-earnings<\/li> <li><strong>57% positive momentum<\/strong> over 10-30 day periods<\/li> <li>Maximum single-day gains reaching <strong>5.39%<\/strong><\/li> <\/ul> <p>The lesson? Smart money looks beyond quarterly losses to pipeline potential and strategic partnerships.<\/p>  [cta_green text=\"Start trading\"]<h2>\ud83d\udcca 6-Month Price Journey: February-August 2025<\/h2> <p>BioNTech shares have delivered an impressive <strong>25.83% gain<\/strong> over the past year, with particularly strong performance in recent months:<\/p> <p><strong>February 2025:<\/strong> ~$89 (post-winter consolidation)<br\/> <strong>April 2025:<\/strong> ~$97 (early pipeline optimism)<br\/> <strong>June 2025:<\/strong> ~$105 (BMS partnership announcement buzz)<br\/> <strong>August 2025:<\/strong> $111.40 (post-earnings strength)<\/p> <p>This upward trajectory reflects growing confidence in BioNTech's transition from COVID-dependent to diversified oncology player. The stock has maintained a healthy trading range between its 52-week low of $81.20 and high of $131.49, currently sitting comfortably in the middle with room for growth.<\/p>  <h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <p>Based on current analyst consensus and pipeline developments, here's what to expect:<\/p> <p><strong>2025 Year-End:<\/strong> $139-150 (25-35% upside) \u2192 <strong>STRONG BUY<\/strong><br\/> Analysts maintain a \"Strong Buy\" rating with average target of $139.49 (<a href=\"https:\/\/stockanalysis.com\/stocks\/bntx\/forecast\/\">StockAnalysis Consensus<\/a>). The recent Bristol Myers Squibb partnership provides immediate validation and cash infusion.<\/p> <p><strong>2026 Forecast:<\/strong> $160-180<br\/> As BNT327 advances through Phase 3 trials and potentially achieves first approvals, expect significant re-rating. The $1.5 billion upfront from BMS funds development without dilution.<\/p> <p><strong>2028 Projection:<\/strong> $200-250<br\/> Multiple product launches expected from the diversified oncology pipeline. BioNTech transforms into a multi-product company beyond mRNA vaccines.<\/p> <p><strong>2030 Vision:<\/strong> $300+<br\/> Full realization of the oncology pipeline potential across multiple cancer types. Personalized mRNA cancer vaccines become standard care.<\/p> <p><strong>Verdict:<\/strong> This is a long-term growth story. Accumulate on dips and hold for the 3-5 year transformation.<\/p>  <h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2> <h3>Risks to Consider:<\/h3> <ul> <li><strong>Clinical Trial Failures:<\/strong> 90% of drug candidates fail - BNT327 setbacks could crater the stock<\/li> <li><strong>Regulatory Hurdles:<\/strong> FDA approvals are never guaranteed, especially for novel mechanisms<\/li> <li><strong>COVID Revenue Decline:<\/strong> Transition away from pandemic profits creates financial pressure<\/li> <li><strong>Competition:<\/strong> Moderna, Pfizer, and dozens of startups chase similar mRNA opportunities<\/li> <li><strong>High Burn Rate:<\/strong> R&amp;D expenses of \u20ac509.1 million last quarter require continued funding<\/li> <\/ul> <h3>Green Lights for 2025-2026:<\/h3> <ul> <li><strong>BMS Partnership Validation:<\/strong> $1.5 billion upfront + $7.6 billion potential milestones = massive vote of confidence<\/li> <li><strong>Diversified Pipeline:<\/strong> 20+ clinical trials across 10+ indications reduces single-asset risk<\/li> <li><strong>Financial Strength:<\/strong> \u20ac16.0 billion cash reserves provide multi-year runway<\/li> <li><strong>Orphan Drug Designation:<\/strong> FDA recognition for BNT327 in small cell lung cancer<\/li> <li><strong>ASCO 2025 Data:<\/strong> Promising results in difficult-to-treat mesothelioma<\/li> <\/ul>  <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <ol> <li><strong>Start Small:<\/strong> Allocate no more than 5% of your portfolio to high-volatility biotech stocks<\/li> <li><strong>Dollar-Cost Average:<\/strong> Buy $100-200 weekly rather than trying to time the perfect entry<\/li> <li><strong>Set Price Alerts:<\/strong> Buy on dips below $105 for better risk-reward ratio<\/li> <li><strong>Think Long-Term:<\/strong> This is a 3-5 year story, not a quick trade<\/li> <\/ol> <p>Humorous veteran advice: \"Trading BioNTech is like watching paint dry while skydiving - long periods of boredom interrupted by moments of sheer terror. The key is not to panic during the scary parts.\"<\/p>  <h2>\u2705 How to Buy BioNTech SE (BNTX) Shares - Step by Step<\/h2> <table border=\"1\" cellspacing=\"0\" cellpadding=\"5\"> <thead> <tr> <th>Step<\/th> <th>Action<\/th> <th>Why It Matters<\/th> <\/tr> <\/thead> <tbody> <tr> <td>1<\/td> <td>Choose a trading platform<\/td> <td>Ensure it offers NASDAQ access and reasonable fees<\/td> <\/tr> <tr> <td>2<\/td> <td>Complete account verification<\/td> <td>Usually takes 1-2 days with proper documentation<\/td> <\/tr> <tr> <td>3<\/td> <td>Deposit funds<\/td> <td>Start with an amount you're comfortable risking<\/td> <\/tr> <tr> <td>4<\/td> <td>Search \"BNTX\"<\/td> <td>Use the ticker symbol, not just \"BioNTech\"<\/td> <\/tr> <tr> <td>5<\/td> <td>Use limit orders<\/td> <td>Set your maximum purchase price to avoid overpaying<\/td> <\/tr> <tr> <td>6<\/td> <td>Review order details<\/td> <td>Check commission fees and settlement dates<\/td> <\/tr> <tr> <td>7<\/td> <td>Execute purchase<\/td> <td>Confirm you're buying the correct number of shares<\/td> <\/tr> <tr> <td>8<\/td> <td>Set price alerts<\/td> <td>Monitor for adding to your position on dips<\/td> <\/tr> <tr> <td>9<\/td> <td>Document your thesis<\/td> <td>Write down why you bought for future reference<\/td> <\/tr> <tr> <td>10<\/td> <td>Practice patience<\/td> <td>Biotech investing requires months\/years, not days<\/td> <\/tr> <\/tbody> <\/table>  <h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2> <p>For those starting their investment journey, Pocket Option offers several advantages for building a position in companies like BioNTech:<\/p> <ul> <li><strong>Minimum deposit amount $5<\/strong> - Test strategies with minimal risk before committing larger amounts<\/li> <li><strong>Rapid verification<\/strong> - Start trading within minutes with simple document upload<\/li> <li><strong>Fractional shares available<\/strong> - Buy portions of expensive stocks like BNTX without needing full share amounts<\/li> <li><strong>100+ withdrawal methods<\/strong> - Access profits through crypto, e-wallets, or traditional banking<\/li> <\/ul> <p>The platform's user-friendly interface makes complex biotech investing accessible to beginners while providing advanced tools for experienced traders looking to capitalize on BioNTech's transformation story.<\/p>  <h2>\ud83c\udf0d BioNTech in 2025: Beyond the Pandemic<\/h2> <p>BioNTech has successfully pivoted from being \"the COVID vaccine company\" to a comprehensive immunotherapy leader. The company now operates four distinct technology platforms spanning mRNA therapeutics, protein-based drugs, cell therapies, and small molecules.<\/p> <p>Current focus areas include:<\/p> <ul> <li><strong>BNT327<\/strong>: Next-generation bispecific antibody targeting PD-L1 and VEGF-A for multiple solid tumors<\/li> <li><strong>Individualized cancer vaccines<\/strong>: Personalized mRNA treatments targeting unique tumor profiles<\/li> <li><strong>Infectious disease pipeline<\/strong>: Ongoing development for malaria, tuberculosis, and other global health priorities<\/li> <li><strong>Manufacturing expansion<\/strong>: African mRNA production initiatives to improve global vaccine access<\/li> <\/ul> <p><strong>2025 Interesting Fact:<\/strong> BioNTech's Mainz headquarters features laboratory elevators that automatically disinfect themselves between floors using UV-C light technology - a pandemic-era innovation that became permanent infrastructure for their infectious disease research facilities.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 BioNTech Stock: Current Price and Critical Dates<\/h2>\n<p>As of August 20, 2025, BioNTech SE (BNTX) trades at <strong>$111.40<\/strong> on the NASDAQ exchange. Mark your calendar: <strong>November 3, 2025<\/strong> is your next major opportunity. That&#8217;s when BioNTech releases its Q3 earnings, and historically, these reports create significant price movements.<\/p>\n<p><strong>Recent Earnings Impact Analysis:<\/strong><br \/> The August 4, 2025 Q2 earnings showed a fascinating pattern &#8211; despite missing EPS estimates (-$1.60 vs. -$1.41 expected), the stock actually gained 0.9% to $111.05 the next day (<a href=\"https:\/\/www.benzinga.com\/analyst-stock-ratings\/price-target\/25\/08\/46866575\/these-analysts-revise-their-forecasts-on-biontech-after-q2-results\">Benzinga Analysis<\/a>). Why? Because revenue smashed expectations at $306.46 million versus $161.26 million forecasted, proving that investors value growth potential over short-term losses in biotech.<\/p>\n<p>This pattern isn&#8217;t new. Over the past six earnings cycles, BioNTech has shown:<\/p>\n<ul>\n<li><strong>50% positive reactions<\/strong> in the first 3 days post-earnings<\/li>\n<li><strong>57% positive momentum<\/strong> over 10-30 day periods<\/li>\n<li>Maximum single-day gains reaching <strong>5.39%<\/strong><\/li>\n<\/ul>\n<p>The lesson? Smart money looks beyond quarterly losses to pipeline potential and strategic partnerships.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6-Month Price Journey: February-August 2025<\/h2>\n<p>BioNTech shares have delivered an impressive <strong>25.83% gain<\/strong> over the past year, with particularly strong performance in recent months:<\/p>\n<p><strong>February 2025:<\/strong> ~$89 (post-winter consolidation)<br \/> <strong>April 2025:<\/strong> ~$97 (early pipeline optimism)<br \/> <strong>June 2025:<\/strong> ~$105 (BMS partnership announcement buzz)<br \/> <strong>August 2025:<\/strong> $111.40 (post-earnings strength)<\/p>\n<p>This upward trajectory reflects growing confidence in BioNTech&#8217;s transition from COVID-dependent to diversified oncology player. The stock has maintained a healthy trading range between its 52-week low of $81.20 and high of $131.49, currently sitting comfortably in the middle with room for growth.<\/p>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<p>Based on current analyst consensus and pipeline developments, here&#8217;s what to expect:<\/p>\n<p><strong>2025 Year-End:<\/strong> $139-150 (25-35% upside) \u2192 <strong>STRONG BUY<\/strong><br \/> Analysts maintain a &#8220;Strong Buy&#8221; rating with average target of $139.49 (<a href=\"https:\/\/stockanalysis.com\/stocks\/bntx\/forecast\/\">StockAnalysis Consensus<\/a>). The recent Bristol Myers Squibb partnership provides immediate validation and cash infusion.<\/p>\n<p><strong>2026 Forecast:<\/strong> $160-180<br \/> As BNT327 advances through Phase 3 trials and potentially achieves first approvals, expect significant re-rating. The $1.5 billion upfront from BMS funds development without dilution.<\/p>\n<p><strong>2028 Projection:<\/strong> $200-250<br \/> Multiple product launches expected from the diversified oncology pipeline. BioNTech transforms into a multi-product company beyond mRNA vaccines.<\/p>\n<p><strong>2030 Vision:<\/strong> $300+<br \/> Full realization of the oncology pipeline potential across multiple cancer types. Personalized mRNA cancer vaccines become standard care.<\/p>\n<p><strong>Verdict:<\/strong> This is a long-term growth story. Accumulate on dips and hold for the 3-5 year transformation.<\/p>\n<h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2>\n<h3>Risks to Consider:<\/h3>\n<ul>\n<li><strong>Clinical Trial Failures:<\/strong> 90% of drug candidates fail &#8211; BNT327 setbacks could crater the stock<\/li>\n<li><strong>Regulatory Hurdles:<\/strong> FDA approvals are never guaranteed, especially for novel mechanisms<\/li>\n<li><strong>COVID Revenue Decline:<\/strong> Transition away from pandemic profits creates financial pressure<\/li>\n<li><strong>Competition:<\/strong> Moderna, Pfizer, and dozens of startups chase similar mRNA opportunities<\/li>\n<li><strong>High Burn Rate:<\/strong> R&amp;D expenses of \u20ac509.1 million last quarter require continued funding<\/li>\n<\/ul>\n<h3>Green Lights for 2025-2026:<\/h3>\n<ul>\n<li><strong>BMS Partnership Validation:<\/strong> $1.5 billion upfront + $7.6 billion potential milestones = massive vote of confidence<\/li>\n<li><strong>Diversified Pipeline:<\/strong> 20+ clinical trials across 10+ indications reduces single-asset risk<\/li>\n<li><strong>Financial Strength:<\/strong> \u20ac16.0 billion cash reserves provide multi-year runway<\/li>\n<li><strong>Orphan Drug Designation:<\/strong> FDA recognition for BNT327 in small cell lung cancer<\/li>\n<li><strong>ASCO 2025 Data:<\/strong> Promising results in difficult-to-treat mesothelioma<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<ol>\n<li><strong>Start Small:<\/strong> Allocate no more than 5% of your portfolio to high-volatility biotech stocks<\/li>\n<li><strong>Dollar-Cost Average:<\/strong> Buy $100-200 weekly rather than trying to time the perfect entry<\/li>\n<li><strong>Set Price Alerts:<\/strong> Buy on dips below $105 for better risk-reward ratio<\/li>\n<li><strong>Think Long-Term:<\/strong> This is a 3-5 year story, not a quick trade<\/li>\n<\/ol>\n<p>Humorous veteran advice: &#8220;Trading BioNTech is like watching paint dry while skydiving &#8211; long periods of boredom interrupted by moments of sheer terror. The key is not to panic during the scary parts.&#8221;<\/p>\n<h2>\u2705 How to Buy BioNTech SE (BNTX) Shares &#8211; Step by Step<\/h2>\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"5\">\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a trading platform<\/td>\n<td>Ensure it offers NASDAQ access and reasonable fees<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete account verification<\/td>\n<td>Usually takes 1-2 days with proper documentation<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Deposit funds<\/td>\n<td>Start with an amount you&#8217;re comfortable risking<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Search &#8220;BNTX&#8221;<\/td>\n<td>Use the ticker symbol, not just &#8220;BioNTech&#8221;<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Use limit orders<\/td>\n<td>Set your maximum purchase price to avoid overpaying<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Review order details<\/td>\n<td>Check commission fees and settlement dates<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Execute purchase<\/td>\n<td>Confirm you&#8217;re buying the correct number of shares<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Set price alerts<\/td>\n<td>Monitor for adding to your position on dips<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Document your thesis<\/td>\n<td>Write down why you bought for future reference<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>Practice patience<\/td>\n<td>Biotech investing requires months\/years, not days<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2>\n<p>For those starting their investment journey, Pocket Option offers several advantages for building a position in companies like BioNTech:<\/p>\n<ul>\n<li><strong>Minimum deposit amount $5<\/strong> &#8211; Test strategies with minimal risk before committing larger amounts<\/li>\n<li><strong>Rapid verification<\/strong> &#8211; Start trading within minutes with simple document upload<\/li>\n<li><strong>Fractional shares available<\/strong> &#8211; Buy portions of expensive stocks like BNTX without needing full share amounts<\/li>\n<li><strong>100+ withdrawal methods<\/strong> &#8211; Access profits through crypto, e-wallets, or traditional banking<\/li>\n<\/ul>\n<p>The platform&#8217;s user-friendly interface makes complex biotech investing accessible to beginners while providing advanced tools for experienced traders looking to capitalize on BioNTech&#8217;s transformation story.<\/p>\n<h2>\ud83c\udf0d BioNTech in 2025: Beyond the Pandemic<\/h2>\n<p>BioNTech has successfully pivoted from being &#8220;the COVID vaccine company&#8221; to a comprehensive immunotherapy leader. The company now operates four distinct technology platforms spanning mRNA therapeutics, protein-based drugs, cell therapies, and small molecules.<\/p>\n<p>Current focus areas include:<\/p>\n<ul>\n<li><strong>BNT327<\/strong>: Next-generation bispecific antibody targeting PD-L1 and VEGF-A for multiple solid tumors<\/li>\n<li><strong>Individualized cancer vaccines<\/strong>: Personalized mRNA treatments targeting unique tumor profiles<\/li>\n<li><strong>Infectious disease pipeline<\/strong>: Ongoing development for malaria, tuberculosis, and other global health priorities<\/li>\n<li><strong>Manufacturing expansion<\/strong>: African mRNA production initiatives to improve global vaccine access<\/li>\n<\/ul>\n<p><strong>2025 Interesting Fact:<\/strong> BioNTech&#8217;s Mainz headquarters features laboratory elevators that automatically disinfect themselves between floors using UV-C light technology &#8211; a pandemic-era innovation that became permanent infrastructure for their infectious disease research facilities.<\/p>\n"},"faq":[{"question":"Is BioNTech only about COVID vaccines?","answer":"No, that was just the beginning. The company's original focus was always cancer treatment, and they're now advancing 20+ clinical trials across multiple oncology indications while maintaining infectious disease capabilities."},{"question":"Why is the stock down from its pandemic highs?","answer":"BioNTech reached $447 in August 2021 due to extraordinary COVID demand. Current prices reflect normalized vaccine revenue but include growing optimism about their cancer pipeline potential."},{"question":"How risky is investing in biotech stocks?","answer":"Very risky - approximately 90% of drug candidates fail clinical trials. However, BioNTech's multiple pipeline assets, strong cash position, and validated technology reduce (but don't eliminate) this risk."},{"question":"Should I wait for a better entry price?","answer":"With analyst targets suggesting 25%+ upside, current levels offer reasonable entry points. Consider dollar-cost averaging rather than trying to time the absolute bottom."},{"question":"What's the most important catalyst to watch?","answer":"Phase 3 data for BNT327 in small cell lung cancer, expected in late 2025\/early 2026. Positive results could double the stock price, while failure would be devastating."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Is BioNTech only about COVID vaccines?","answer":"No, that was just the beginning. The company's original focus was always cancer treatment, and they're now advancing 20+ clinical trials across multiple oncology indications while maintaining infectious disease capabilities."},{"question":"Why is the stock down from its pandemic highs?","answer":"BioNTech reached $447 in August 2021 due to extraordinary COVID demand. Current prices reflect normalized vaccine revenue but include growing optimism about their cancer pipeline potential."},{"question":"How risky is investing in biotech stocks?","answer":"Very risky - approximately 90% of drug candidates fail clinical trials. However, BioNTech's multiple pipeline assets, strong cash position, and validated technology reduce (but don't eliminate) this risk."},{"question":"Should I wait for a better entry price?","answer":"With analyst targets suggesting 25%+ upside, current levels offer reasonable entry points. Consider dollar-cost averaging rather than trying to time the absolute bottom."},{"question":"What's the most important catalyst to watch?","answer":"Phase 3 data for BNT327 in small cell lung cancer, expected in late 2025\/early 2026. Positive results could double the stock price, while failure would be devastating."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy BioNTech SE (BNTX) shares - Investment in BioNTech SE (BNTX) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy BioNTech SE (BNTX) shares - Investment in BioNTech SE (BNTX) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T18:36:33+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy BioNTech SE (BNTX) shares &#8211; Investment in BioNTech SE (BNTX) stock\",\"datePublished\":\"2025-08-20T18:36:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/\"},\"wordCount\":15,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/\",\"name\":\"How to buy BioNTech SE (BNTX) shares - Investment in BioNTech SE (BNTX) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"datePublished\":\"2025-08-20T18:36:33+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy BioNTech SE (BNTX) shares &#8211; Investment in BioNTech SE (BNTX) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy BioNTech SE (BNTX) shares - Investment in BioNTech SE (BNTX) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/","og_locale":"en_US","og_type":"article","og_title":"How to buy BioNTech SE (BNTX) shares - Investment in BioNTech SE (BNTX) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-20T18:36:33+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy BioNTech SE (BNTX) shares &#8211; Investment in BioNTech SE (BNTX) stock","datePublished":"2025-08-20T18:36:33+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/"},"wordCount":15,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/","name":"How to buy BioNTech SE (BNTX) shares - Investment in BioNTech SE (BNTX) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","datePublished":"2025-08-20T18:36:33+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-biontech-se\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy BioNTech SE (BNTX) shares &#8211; Investment in BioNTech SE (BNTX) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":342654,"slug":"how-to-buy-biontech-se","post_title":"Comment acheter des actions BioNTech SE (BNTX) - Investir dans l'action BioNTech SE (BNTX)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-biontech-se\/"},"it_IT":{"locale":"it_IT","id":342657,"slug":"how-to-buy-biontech-se","post_title":"Come acquistare azioni BioNTech SE (BNTX) - Investire in azioni BioNTech SE (BNTX)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-biontech-se\/"},"pl_PL":{"locale":"pl_PL","id":342656,"slug":"how-to-buy-biontech-se","post_title":"Jak kupi\u0107 akcje BioNTech SE (BNTX) - Inwestycja w akcje BioNTech SE (BNTX)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-biontech-se\/"},"es_ES":{"locale":"es_ES","id":342659,"slug":"how-to-buy-biontech-se","post_title":"C\u00f3mo comprar acciones de BioNTech SE (BNTX) - Inversi\u00f3n en acciones de BioNTech SE (BNTX)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-biontech-se\/"},"th_TH":{"locale":"th_TH","id":342660,"slug":"how-to-buy-biontech-se","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 BioNTech SE (BNTX) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 BioNTech SE (BNTX)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-biontech-se\/"},"tr_TR":{"locale":"tr_TR","id":342661,"slug":"how-to-buy-biontech-se","post_title":"BioNTech SE (BNTX) Hisseleri Nas\u0131l Al\u0131n\u0131r - BioNTech SE (BNTX) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-biontech-se\/"},"vt_VT":{"locale":"vt_VT","id":342658,"slug":"how-to-buy-biontech-se","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu BioNTech SE (BNTX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu BioNTech SE (BNTX)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-biontech-se\/"},"pt_AA":{"locale":"pt_AA","id":342655,"slug":"how-to-buy-biontech-se","post_title":"Como comprar a\u00e7\u00f5es da BioNTech SE (BNTX) - Investimento em a\u00e7\u00f5es da BioNTech SE (BNTX)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-biontech-se\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/342593","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=342593"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/342593\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334027"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=342593"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=342593"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=342593"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}